コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ine Panc-1 is dependent on the expression of annexin A2.
2 e targets, Rab14, co-immunoprecipitated with annexin A2.
3 d S100A10, a dimeric protein associated with annexin A2.
4 licit a significant conformational change in annexin A2.
5 mplexes of heparin oligosaccharides bound to annexin A2.
6 situated at the convex face of domain IV of annexin A2.
7 the calcium dependence of heparin binding to annexin A2.
8 Lys279 and Lys281, on the convex surface of annexin A2.
9 ent manner after binding of beta(2)GPI to EC annexin A2.
10 ction of tPA required its membrane receptor, annexin A2.
13 apoptosis in host cells by interacting with annexin A2, a novel virulence mechanism in Mycoplasma ga
14 IR requires transcriptional induction of the annexin A2 (A2) gene through the direct action of the hy
19 endosomal tubules along microtubules to the Annexin A2/actin-dependent stabilization and detachment
20 (A2t) of p11 and annexin A2, but not p11 or annexin A2 alone, directly binds cPLA(2)alpha via Ser(72
21 r annexins and mu subunits demonstrated that annexin A2 also binds the mu1 subunit of the AP-1 comple
22 uired for transport (ESCRT) machinery and on Annexin A2, an RNA-binding protein involved in membrane
26 d that the two phospholipid-binding proteins annexin A2 and A5 are, beside DNA, significant C1q ligan
27 whereas the anti-inflammatory proteins (e.g. Annexin A2 and Annexin A6) were significantly upregulate
29 ochemical analyses confirmed localization of annexin A2 and glyceraldehyde 3-dehydrogenase (GAPDH), p
31 s were made for binding interactions between annexin A2 and heparin polysaccharide in solution at pH
32 an anti-inflammatory tick protein, binds to annexin A2 and impairs the formation of the NLRC4 inflam
34 ells exhibit a perinuclear redistribution of annexin A2 and p11 and show increased fusion of perinucl
36 ibition of MMP-1 production with Abs against annexin A2 and S100A10, a dimeric protein associated wit
37 obtained at high resolution for uncomplexed annexin A2 and three complexes of heparin oligosaccharid
38 gnized functional link between intracellular annexin A2 and tumor cell adhesion, migration and in viv
39 in which the N-terminal and core domains of annexins A2 and A5 were swapped showed that trimer forma
40 confirmed that GroEL proteins could bind to annexin A2, and confocal analysis further demonstrated t
41 several SNPs in bone morphogenic protein 6, annexin A2, and klotho were associated with sickle cell
42 be more important than ANG association with annexin A2, and KSHV probably uses annexin A2 to maintai
45 In triple-staining analyses, we observed annexin A2-ANG-LANA-1, annexin A2-ANG, and ANG-LANA-1 co
46 studies suggest that LANA-1 association with annexin A2/ANG could be more important than ANG associat
47 tion, but blocked activation induced by anti-annexin A2 antibodies and F(ab')2 fragments, as well as
48 sence of beta2GPI, and demonstrate that anti-annexin A2 antibodies directly cause endothelial cell ac
49 , we show that similar to dysferlin, lack of annexin A2 (AnxA2) also results in poor myofiber repair
51 Human-derived H1650 SP cells over-express annexin A2 (AnxA2) and SOX2, and are resistant to conven
53 1R phosphorylated the prometastatic molecule Annexin A2 (AnxA2) at Y23 and Y333 in response to stroma
56 ion of plasmin, a key fibrinolytic agent, by annexin A2 (ANXA2) distinctly impacts progression of BCR
57 eport that the phospholipid-binding protein, annexin A2 (ANXA2) functions to maintain vascular integr
59 novel role for the membrane binding protein Annexin A2 (ANXA2) in modulating the composition of spec
66 ach we uncovered the physical association of Annexin A2 (AnxA2) with native TRPA1 in mouse sensory ne
69 revealed the relevant target of PY-60 to be annexin A2 (ANXA2), a protein that directly associates w
70 membrane-associated, actin binding protein, annexin A2 (AnxA2), is up-regulated in migrating IECs an
72 -206 directly targets the oncogenes KRAS and annexin a2 (ANXA2), thereby acting as tumor suppressor i
73 ne peripherally associated membrane protein, annexin A2 (AnxA2), to induce the formation of phosphati
74 n the membrane phospholipid binding protein, annexin A2 (ANXA2), we observed a significant decrease i
75 followed by mass spectrometry, we identified annexin A2 (ANXA2), which binds actin and cellular membr
76 We also identify the S100A10 subunit of the annexin A2 (AnxA2)-S100A10 protein complex as a novel Mu
82 tif that binds to and inhibits intracellular annexin A2 as a candidate therapeutic lead for potential
88 , vimentin, actin, caldesmon, myosin IC, and annexin A2 as major proteins and was noted to exhibit co
89 creased MMP-1 synthesis by signaling through annexin A2, as demonstrated by inhibition of MMP-1 produ
92 r, the results indicate a functional role of annexin A2 binding to endosomal membranes following orga
93 he current study, we show that extracellular annexin A2 binds to the region of Factor H encompassing
95 howed that a heterotetramer (A2t) of p11 and annexin A2, but not p11 or annexin A2 alone, directly bi
101 graphy showed that cortical actin bundled by annexin A2 connected docked secretory granules to the pl
102 that the membrane curvature-inducing protein annexin A2 contributes to the formation of these vesicle
106 tion of retinal pigment epithelial cells are annexin A2-dependent, and stimulated by macrophage infla
110 our findings demonstrate that inhibition of annexin A2 expression in glioma cells could become a new
111 associated proteins, we silenced endogenous annexin A2 expression in rat alveolar type II cells by R
114 uced kidney injury in mice and deficiency of annexin A2 expression reduces complement activation on t
115 nt GroEL protein in PBMCs, and knocking down annexin A2 expression resulted in significantly reduced
122 onation, confocal analysis of endogenous and annexin A2-GFP transfected cells, and immunogold labelli
125 asmon resonance analysis showed that A2t and annexin A2 has modest selectivity for PtdIns(4,5)P2 over
135 , we report that the levels of expression of annexin A2 in human glioma samples correlate with their
137 a membrane repair in general and S100A11 and Annexin A2 in particular as new targets for the therapy
138 er, our analyses highlight the importance of annexin A2 in vesiculation of a population of Atg16L-pos
139 ic distribution in normal tissue (prohibitin/annexin A2 in white adipose tissue) or cancer (RAGE/leuk
140 protein) and endogenous genes (lamin A/C and annexin A2) in alveolar type II cells, but not other lun
141 a glycoprotein (gD), and a cellular protein (annexin A2) in the primary enveloped virion preparation.
142 mococcal otitis media, the administration of annexin A2 increased AP-mediated bacterial opsonization
144 Furthermore, binding of inactive plasmin to annexin A2 inhibited plasmin induction of MMP-1, suggest
148 kidney transcription datasets revealed that annexin A2 is expressed by several cell types in the kid
158 results provide clear evidence that CD44 and annexin A2 mediate the C5a chemotactic cofactor function
159 an ERK-independent pathway to promote rapid annexin A2 membrane recruitment and enhance microvesicle
160 reveal that dysfunction of the BLOC-1-KIF13A-Annexin A2 molecular network underlies the pathophysiolo
163 1 production is seen in dendritic cells from annexin A2-null mice, following exposure to polyethylene
164 S TX binds to human surfactant protein A and annexin A2 on airway epithelial cells and is internalize
165 ed that beta2GPI binds with high affinity to annexin A2 on the endothelial surface, though the releva
167 of mice with intraocular antibody to either annexin A2 or macrophage inflammatory protein dampens th
168 show that siRNA-mediated knockdown of either annexin a2 or p11 protein significantly inhibits C-1-P-d
171 ular C-1-P, acting through the extracellular annexin a2-p11 heterotetrameric protein, can mediate vas
172 ared dye selectively binds to phosphorylated Annexin A2 (pANXA2), with high affinity at high levels o
177 hese data suggest that reduced expression of annexin A2 protein is associated with cell surface hypof
178 lococcal leukotoxin E) and eukaryotic (human annexin A2 protein tagged with mouse IgG1) recombinant p
180 ments, using fluorescent liposomes, confirms annexin A2 recruitment to endosomes containing phagocyto
188 sma phagocytophilum Macrophages deficient in annexin A2 secreted significantly smaller amounts of int
189 rescued by overexpressing EGFP-tagged human annexin A2, six of seven selected targets returned to th
191 peripheral blood mononuclear cells and other annexin A2-specific Vdelta2(neg) gammadelta T-cell clone
193 activation by posttranslationally modifying annexin A2, the coreceptor for plasminogen and tissue pl
194 apable of binding to target proteins such as annexin A2, the tumor-suppressor protein p53 and myosin
197 different lengths were co-crystallized with annexin A2 to elucidate the structural basis of the inte
198 tion with annexin A2, and KSHV probably uses annexin A2 to maintain the viability and cell cycle regu
199 l support to our findings, better binding of annexin A2 to sialostatin L2 in sera from 21 out of 23 i
202 raldehyde 3-phosphate dehydrogenase (G3PDH), annexin A2, triose phosphate isomerase, and ubiquitin B
204 cium, and to be functional in the sense that annexin A2 was able to recruit the mu2 to immobilized li
206 The interaction between mu2 and full-length annexin A2 was demonstrated in vitro to be direct, to re
209 ication and mass spectrometry, intracellular annexin A2 was identified as the corresponding binding p
210 entify antigenic ligands of gammadelta TCRs, annexin A2 was identified as the direct ligand of Vgamma
215 that interact with the N-terminal domain of annexin A2 we identified the mu2 subunit of the clathrin
217 ut not nonphosphorylated PS1, interacts with Annexin A2, which, in turn, interacts with the lysosomal
218 etermined the membrane binding properties of annexin A2 wild type and mutants both as monomer and as
219 ogen activation through its interaction with annexin A2 with concomitant reduced plasmin generation b
220 A induced the aggregation and interaction of annexin A2 with integrin CD11b, and ablation of CD11b or